These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6831478)

  • 1. PCNU in advanced breast cancer.
    Martino S; Samal BA; Singhakowinta A
    Cancer Treat Rep; 1983 Mar; 67(3):305-6. PubMed ID: 6831478
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trail of PCNU in refractory advanced breast cancer.
    Kavanagh JJ; Yap HY; Blumenschein GR; Stewart D; Bodey GP
    Am J Clin Oncol; 1982 Jun; 5(3):249-51. PubMed ID: 7081144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of PCNU in breast carcinoma.
    Rubins JM; Taylor SG
    Invest New Drugs; 1989 Jul; 7(2-3):239-41. PubMed ID: 2793380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
    Hansen M; Palshof T; Osterlind K; Hansen HH; Mouridsen H
    Cancer Treat Rep; 1977 Nov; 61(8):1603-5. PubMed ID: 922762
    [No Abstract]   [Full Text] [Related]  

  • 6. PCNU in advanced adenocarcinoma of the ovary: a phase II study.
    Decker DA; Samson MJ; Baker LH
    Cancer Treat Rep; 1983 May; 67(5):511-2. PubMed ID: 6850668
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of PCNU in advanced renal cell carcinoma and malignant melanoma.
    Harvey JH; Smith FP; Bowers MW; Neefe JR; Butler TP; Gullo JJ; Schertz G; Lokey J; Schein PS; Woolley PV
    Cancer Treat Rep; 1984; 68(7-8):1049-50. PubMed ID: 6744340
    [No Abstract]   [Full Text] [Related]  

  • 9. The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Ahmann DL
    Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
    [No Abstract]   [Full Text] [Related]  

  • 10. PCNU treatment for recurrent malignant gliomas.
    Levin VA; Resser KJ; McGrath L; Vestnys P; Nutik S; Wilson CB
    Cancer Treat Rep; 1984; 68(7-8):969-73. PubMed ID: 6744348
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of PCNU in colorectal carcinoma.
    Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
    Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of TCNU in advanced breast cancer.
    Dombernowsky P; Clavel M; Smyth JF; Howell A; van Glabekke M; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1377-8. PubMed ID: 3181260
    [No Abstract]   [Full Text] [Related]  

  • 13. PCNU Phase I study in the North California Oncology Group.
    Friedman MA
    Recent Results Cancer Res; 1981; 76():125-9. PubMed ID: 7232846
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 15. Adriamycin and CCNU in the treatment of advanced breast cancer.
    Muss HB; White DR; Richards F; Cooper MR; Spurr CL
    Cancer Treat Rep; 1976 Nov; 60(11):1687-9. PubMed ID: 1021240
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA; Liu J; Weinkam RJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New cytostatics in oncological therapy].
    Osieka R; Seeber S; Bruntsch U; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2468-74. PubMed ID: 4141307
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete remissions in chemotherapy of lung cancer models induced in mice by asbestos.
    Smith WE; Hubert DD; Yazdi E; Holiat SM; Bissell EC; Watts LM; Baylouny RA; Sobel HJ
    Mt Sinai J Med; 2005 Jan; 72(1):23-32. PubMed ID: 15682259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the status of the nitrosoureas in other tumors.
    Carter SK
    Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
    [No Abstract]   [Full Text] [Related]  

  • 20. Solid tumor chemotherapy: new drugs and horizons.
    Yardumian H
    J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.